FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 251 filers reported holding FATE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60,488 | -50.4% | 28,532 | +11.3% | 0.00% | – |
| Q2 2023 | $122,023 | -6.7% | 25,635 | +11.7% | 0.00% | – |
| Q1 2023 | $130,815 | -47.4% | 22,950 | -7.0% | 0.00% | – |
| Q4 2022 | $248,880 | -52.2% | 24,666 | +6.1% | 0.00% | – |
| Q3 2022 | $521,000 | -11.4% | 23,250 | -2.0% | 0.00% | – |
| Q2 2022 | $588,000 | -41.1% | 23,715 | -8.0% | 0.00% | -100.0% |
| Q1 2022 | $999,000 | -75.5% | 25,768 | -63.0% | 0.00% | -50.0% |
| Q4 2021 | $4,075,000 | -14.3% | 69,659 | -13.2% | 0.00% | -33.3% |
| Q3 2021 | $4,757,000 | -67.0% | 80,264 | -51.6% | 0.00% | -66.7% |
| Q2 2021 | $14,402,000 | -18.2% | 165,934 | -22.3% | 0.01% | -25.0% |
| Q1 2021 | $17,610,000 | +436.9% | 213,586 | +492.0% | 0.01% | +500.0% |
| Q4 2020 | $3,280,000 | +205.7% | 36,076 | +34.4% | 0.00% | +100.0% |
| Q3 2020 | $1,073,000 | +16.8% | 26,849 | +0.3% | 0.00% | 0.0% |
| Q2 2020 | $919,000 | +315.8% | 26,780 | +168.8% | 0.00% | – |
| Q1 2020 | $221,000 | +39.0% | 9,964 | -2.6% | 0.00% | – |
| Q3 2019 | $159,000 | -20.9% | 10,225 | +3.1% | 0.00% | – |
| Q2 2019 | $201,000 | -62.0% | 9,913 | -96.6% | 0.00% | -100.0% |
| Q1 2016 | $529,000 | -55.2% | 293,900 | -16.2% | 0.00% | -50.0% |
| Q4 2015 | $1,182,000 | -36.8% | 350,800 | 0.0% | 0.00% | -33.3% |
| Q3 2015 | $1,870,000 | -17.4% | 350,800 | +0.2% | 0.00% | 0.0% |
| Q2 2015 | $2,265,000 | +121.0% | 350,000 | +67.0% | 0.00% | +50.0% |
| Q1 2015 | $1,025,000 | -1.9% | 209,600 | +0.9% | 0.00% | 0.0% |
| Q4 2014 | $1,045,000 | +0.1% | 207,700 | +2.3% | 0.00% | 0.0% |
| Q3 2014 | $1,044,000 | -18.9% | 203,100 | -0.4% | 0.00% | 0.0% |
| Q2 2014 | $1,287,000 | -35.2% | 204,000 | 0.0% | 0.00% | -50.0% |
| Q1 2014 | $1,987,000 | +56.7% | 204,000 | +1.0% | 0.00% | +100.0% |
| Q4 2013 | $1,268,000 | – | 201,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |